Home › Left Ventricular Dysfunction › Pennsylvania
Left Ventricular Dysfunction clinical trials in Pennsylvania
3 studies for Left Ventricular Dysfunction are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Children's Hospital of Philadelphia (CHOP) ( Site 0004), Philadelphia
- Children's Hospital of Pittsburgh ( Site 0010), Pittsburgh
RecruitingPhase 2/3
29 Days – 17 Years · All sexes · Updated Aug 28, 2026 · NCT05714085A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Children's Hospital of Philadelphia - Cardiology, Philadelphia
- UPMC Children's Hospital of Pittsburgh - Cardiology, Pittsburgh
RecruitingPhase 3
Up to age 18 · All sexes · Updated Jun 29, 2026 · NCT07192952A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Children's Hospital of Philadelphia - Cardiology, Philadelphia
- UPMC Children's Hospital of Pittsburgh - Cardiology, Pittsburgh
RecruitingPhase 3
6 Months – 17 Years · All sexes · Updated Jun 15, 2026 · NCT07188805From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.